Team:SupBiotech-Paris/Concept
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
Line 3: | Line 3: | ||
<span style="float: right">[[Team:SupBiotech-Paris/Introduction1#drapeau|Back to top]]</span> | <span style="float: right">[[Team:SupBiotech-Paris/Introduction1#drapeau|Back to top]]</span> | ||
+ | |||
+ | |||
+ | {| class="wikitable" width="80%" align="center" | ||
+ | |+ Tableau | ||
+ | |- | ||
+ | ! scope=col | | ||
+ | ! scope=col | Stabilité | ||
+ | ! scope=col | Toxicité | ||
+ | ! scope=col | Ciblage | ||
+ | ! scope=col | Passage des membranes | ||
+ | ! scope=col | Résistance au Syst. Immun. | ||
+ | ! scope=col | Industrialisation | ||
+ | |- | ||
+ | | width="33%" | | ||
+ | Virus | ||
+ | | width="34%" | | ||
+ | Bonne | ||
+ | | width="34%" | | ||
+ | Forte | ||
+ | | width="34%" | | ||
+ | Cellulaire | ||
+ | | width="34%" | | ||
+ | Très Bon | ||
+ | | width="34%" | | ||
+ | Nulle | ||
+ | | width="34%" | | ||
+ | Difficile | ||
+ | |- | ||
+ | | width="33%" | | ||
+ | Phage | ||
+ | | width="34%" | | ||
+ | Bonne | ||
+ | | width="34%" | | ||
+ | Faible | ||
+ | | width="34%" | | ||
+ | Cellulaire | ||
+ | | width="34%" | | ||
+ | Faible | ||
+ | | width="34%" | | ||
+ | Nulle | ||
+ | | width="34%" | | ||
+ | Facile | ||
+ | |- | ||
+ | | width="33%" | | ||
+ | Bactérie | ||
+ | | width="34%" | | ||
+ | Bonne | ||
+ | | width="34%" | | ||
+ | Faible/Forte | ||
+ | | width="34%" | | ||
+ | Tissulaire | ||
+ | | width="34%" | | ||
+ | Nulle | ||
+ | | width="34%" | | ||
+ | Faible/Forte | ||
+ | | width="34%" | | ||
+ | Facile | ||
+ | |- | ||
+ | | width="33%" | | ||
+ | Nanoparticule lipidique | ||
+ | | width="34%" | | ||
+ | Faible | ||
+ | | width="34%" | | ||
+ | Faible | ||
+ | | width="34%" | | ||
+ | Cellulaire | ||
+ | | width="34%" | | ||
+ | Moyen | ||
+ | | width="34%" | | ||
+ | Faible | ||
+ | | width="34%" | | ||
+ | Moyenne | ||
+ | Nanoparticule polymère | ||
+ | | width="34%" | | ||
+ | Bonne | ||
+ | | width="34%" | | ||
+ | Moyenne | ||
+ | | width="34%" | | ||
+ | Cellulaire | ||
+ | | width="34%" | | ||
+ | Faible | ||
+ | | width="34%" | | ||
+ | Faible | ||
+ | | width="34%" | | ||
+ | Moyenne | ||
+ | |} |
Revision as of 12:36, 14 October 2009
Stabilité | Toxicité | Ciblage | Passage des membranes | Résistance au Syst. Immun. | Industrialisation | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Virus |
Bonne |
Forte |
Cellulaire |
Très Bon |
Nulle |
Difficile | ||||||
Phage |
Bonne |
Faible |
Cellulaire |
Faible |
Nulle |
Facile | ||||||
Bactérie |
Bonne |
Faible/Forte |
Tissulaire |
Nulle |
Faible/Forte |
Facile | ||||||
Nanoparticule lipidique |
Faible |
Faible |
Cellulaire |
Moyen |
Faible |
Moyenne Nanoparticule polymère |
Bonne |
Moyenne |
Cellulaire |
Faible |
Faible |
Moyenne |